SARS-CoV2: should inhibitors of the renin–angiotensin system be withdrawn in patients with COVID-19?
Gabriela M. Kuster, Otmar Pfister, Thilo Burkard, Qian Zhou, Raphael Twerenbold, Philip Haaf, Andreas F. Widmer, Stefan Osswald
Abstract
Abstract
Topics & Concepts
MedicineCoronavirus disease 2019 (COVID-19)Renin–angiotensin system2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirologyPeptidyl-Dipeptidase ABetacoronavirusInternal medicinePharmacologyBlood pressureOutbreakInfectious disease (medical specialty)DiseaseCOVID-19 Clinical Research StudiesHeart Rate Variability and Autonomic ControlHeart rate and cardiovascular health